Piper Sandler initiated coverage of Compass Therapeutics (CMPX) with an Overweight rating and $12 price target The company is developing a ...

In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Boston Scientific (BSX – Research Report), with a ...

On Feb. 12, the Mercer Island School Board publicly censured director Dan Glowitz in a 4-to-1 vote for violating the “board’s ...

Reddit shares tumbled 13 per cent in premarket trading on Thursday after the social media firm missed expectations for daily ...

Smith Haven Mall is slated to get a multimillion-dollar makeover that will include new stores, dining destinations, an ...

Fintel reports that on February 7, 2025, Piper Sandler upgraded their outlook for Nevro (NYSE:NVRO) from Underweight to ...

Piper Sandler Companies had a return on equity of 17.00% and a net margin of 11.87%. During the same period in the previous year, the business earned $4.03 earnings per share.

Piper Sandler Companies has a one year low of $177.80 and a one year high of $351.80. The stock has a market capitalization of $5.69 billion, a P/E ratio of 31.29 and a beta of 1.46.

Piper Sandler Companies reported robust financial results for Q4 2024, significantly surpassing analyst expectations. The company achieved earnings per share (EPS) of $4.80, exceeding the forecasted ...

Good morning, and welcome to the Piper Sandler Companies fourth quarter and full year 2024 earnings conference call. Today's call is being recorded and will include remarks by Piper Sandler management ...